Refine
Year of publication
Document Type
- Preprint (570)
- Article (384)
- Conference Proceeding (7)
- Working Paper (4)
- Book (1)
- Part of a Book (1)
Has Fulltext
- yes (967)
Is part of the Bibliography
- no (967)
Keywords
- Heavy Ion Experiments (18)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- Hadron-Hadron Scattering (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- glioblastoma (3)
- pp collisions (3)
- Acute myeloid leukemia (2)
- Beauty production (2)
- Charm physics (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- HOD (2)
- Induction chemotherapy (2)
- Intensive care treatment (2)
- Jets (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Polymers (2)
- Single electrons (2)
- Survival (2)
- glioma (2)
- resilience (2)
- 900 GeV (1)
- ACLF (1)
- ALICE detector (1)
- AML (1)
- ASCT (1)
- ATR-FTIR (1)
- Abundance (1)
- Acute kidney failure (1)
- Alzheimer’s dementia (1)
- Amyloid-beta 42 (1)
- Anti-kaon–nucleon physics (1)
- Anti-nuclei (1)
- Aphasia (1)
- Aphasie (1)
- Arcuate fascicle (1)
- Atomic and Molecular Physics (1)
- Autecology (1)
- BRAF (1)
- BRAF V600E (1)
- Baryonic resonances (1)
- Biomarkers (1)
- Bone marrow aspiration (1)
- Brain metastasis (1)
- Brain tumor (1)
- Breast cancer (1)
- CBC (1)
- CHIP (1)
- CLOUD experiment (1)
- CMS (1)
- CVID (1)
- Cancer treatment (1)
- Centrality Class (1)
- Centrality Selection (1)
- Chemistry (1)
- Collective Flow (1)
- Comparison with QCD (1)
- Ecology (1)
- Ecotoxicology (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Ellenberg indicator values (1)
- Elliptic flow (1)
- Environmental quality (1)
- Environmental sciences (1)
- European Society for Immunodeficiencies (ESID) (1)
- Fasciculus arcuatus (1)
- Feeding types (1)
- Femtoscopy (1)
- Festuco-Brometea (1)
- Fibre/foam sandwich radiator (1)
- Fluid overload (1)
- Freezeout (1)
- Freshwater (1)
- German PID-NET registry (1)
- Glioma (1)
- HBT (1)
- HVPG (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Heavy Ion Experiment (1)
- Heavy Quark Production (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Heavy-ion reactions (1)
- Hippocampal volume (1)
- Hirninfarkt (1)
- Holmes tremor (1)
- Hyperons (1)
- IgG substitution therapy (1)
- Imidacloprid (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Invertebrates (1)
- Ionisation energy loss (1)
- Ischemic stroke (1)
- Kaonic nuclei (1)
- Kollisionen schwerer Ionen (1)
- Lacunar (1)
- Lakunär (1)
- Lesions (1)
- Litter (1)
- Low energy QCD (1)
- MRI (1)
- Microplastic-biota interaction (1)
- Microplastics (1)
- Mid-rapidity (1)
- Mild cognitive impairment (1)
- Minimum Bias (1)
- Molecular matched therapy (1)
- Molecular profiling (1)
- Monitoring (1)
- Monte Carlo (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiple stressors (1)
- Nanoplastics (1)
- Necrosis (1)
- Neural network (1)
- Non-small cell lung cancer (1)
- Nuclear modification factor (1)
- Nucleus (1)
- PID prevalence (1)
- PXA (1)
- PYTHIA (1)
- Partial wave analysis (1)
- Particle Correlations and Fluctuations (1)
- Pb–Pb (1)
- Peripheral blood smears (1)
- Phospho-tau (1)
- Plastic polymers (1)
- Plastics (1)
- Prediction (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton (1)
- Proton–proton (1)
- Pyrolysis GC–MS (1)
- QCD (1)
- QMD (1)
- Quantenmolekulardynamik (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Rapidity Range (1)
- Relapse surveillance (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- Review (1)
- Single muons (1)
- Stereotactic radiosurgery (1)
- Strangeness (1)
- Subcortical (1)
- Subkortikal (1)
- Suspended solids (1)
- Systematic Uncertainty (1)
- TR (1)
- Targeted therapy (1)
- Tau (1)
- Thermal desorption GC–MS (1)
- Time Projection Chamber (1)
- Toxicity (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Vector (1)
- Vector Boson Production (1)
- Visual analysis (1)
- Water framework directive (1)
- Xenon-based gas mixture (1)
- acute decompensation (1)
- aerosol formation (1)
- aerosols (1)
- anti-angiogenic therapy (1)
- asset pricing (1)
- autologous stem cell transplantation (1)
- bevacizumab (1)
- cerebellar mutism (1)
- cerebellum (1)
- chemotherapy (1)
- cirrhosis (1)
- clonal dominance (1)
- clonal hematopoiesis (1)
- cortex, gray matter (1)
- credit risk (1)
- dE/dx (1)
- dabrafenib (1)
- diffusion tensor imaging (1)
- dispersal (1)
- ecological strategy (1)
- equity options (1)
- fractional anisotropy (1)
- gliomatosis cerebri growth pattern (1)
- heavy ion collisions (1)
- heavy ion experiments (1)
- hematopoietic stem cells (1)
- hematopoietic stress (1)
- hydrocephalus (1)
- hypoxia (1)
- intestinal manipulation (1)
- intraventricular chemotherapy (1)
- isolation (1)
- leptomeningeal disease (1)
- leptomeningeal metastases (1)
- leukemia (1)
- low risk anomaly (1)
- mean diffusivity (1)
- medulloblastoma (1)
- medulloblastoma resection (1)
- mowing (1)
- multiple sclerosis (1)
- nanoparticle growth (1)
- naturalness (1)
- neurosurgery (1)
- palatal tremor (1)
- pandemics (1)
- patterns of progression (1)
- perioperative ischemia (1)
- phenology (1)
- plant traits (1)
- pleomorphic xanthoastrocytoma (1)
- portal pressure (1)
- posterior fossa masses (1)
- ppK − (1)
- primary brain tumors (1)
- primary immunodeficiency (PID) (1)
- quant molekular dynamic (1)
- quark gluon plasma (1)
- rare disasters (1)
- registry for primary immunodeficiency (1)
- risk premia (1)
- skewness (1)
- social distance (1)
- somatic mutations (1)
- spectra (1)
- surgery (1)
- ventriculoperitoneal shunt (1)
- volatile organic compounds (1)
- √sN N = 2.76 TeV (1)
Institute
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
(2017)
Bevacizumab has been shown to improve progression-free survival and neurologic function, but failed to improve overall survival in newly diagnosed glioblastoma and at first recurrence. Nonetheless, bevacizumab is widely used in patients with recurrent glioma. However, its use in patients with gliomas showing a gliomatosis cerebri growth pattern is contentious. Due to the marked diffuse and infiltrative growth with less angiogenic tumor growth, it may appear questionable whether bevacizumab can have a therapeutic effect in those patients. However, the development of nodular, necrotic, and/or contrast-enhancing lesions in patients with a gliomatosis cerebri growth pattern is not uncommon and may indicate focal neo-angiogenesis. Therefore, control of growth of these lesions as well as control of edema and reduction of steroid use may be regarded as rationales for the use of bevacizumab in these patients. In this retrospective patient series, we report on 17 patients with primary brain tumors displaying a gliomatosis cerebri growth pattern (including seven glioblastomas, two anaplastic astrocytomas, one anaplastic oligodendroglioma, and seven diffuse astrocytomas). Patients have been treated with bevacizumab alone or in combination with lomustine or irinotecan. Seventeen matched patients treated with bevacizumab for gliomas with a classical growth pattern served as a control cohort. Response rate, progression-free survival, and overall survival were similar in both groups. Based on these results, anti-angiogenic therapy with bevacizumab should also be considered in patients suffering from gliomas with a mainly infiltrative phenotype.
Hintergrund: Aphasien gehören nicht zu den typischen klinischen Manifestationen lakunärer Hirninfarkte, sind jedoch im Rahmen seltener atypischer lakunärer Syndrome beschrieben.
Ziel der Arbeit: Beschreibung von Aphasiemustern und betroffener Fasertrakte bei lakunären Infarkten.
Material und Methoden: Fallserie von drei Patienten mit in der Magnetresonanztomographie nachgewiesenen lakunären Hirninfarkten und Aphasie. Identifikation betroffener Faserbahnen mittels Fasertraktographie der koregistrierten Schädigungsorte in Gehirnen zweier gesunder Probanden.
Ergebnisse: Radiologisch waren die Lakunen, die Aphasien hervorriefen, weit lateral im Marklager der linken Hemisphäre gelegen und befanden sich im Vergleich zu der Lakune eines nichtaphasischen Kontrollpatienten weiter rostrodorsal. Klinisch fand sich trotz Aussparung des Kortex, Thalamus und weiter Teile der Basalganglien eine leichte bis moderate nichtflüssige Aphasie mit syntaktischen Defiziten. In der Fasertraktographie zeigten die aphasischen im Vergleich zum nichtaphasischen Patienten eine stärkere Affektion der Fasern des linken Fasciculus arcuatus sowie eine Beteiligung des frontostriatalen und frontalen Aslant-Trakts.
Diskussion: Links lateral gelegene lakunäre Infarkte können durch Beteiligung sprachrelevanter Fasertrakte eine klinisch relevante Aphasie hervorrufen.
The optimal follow-up care for relapse detection in acute myeloid leukemia (AML) patients in first remission after consolidation therapy with intensive chemotherapy is not established. In this retrospective study, we evaluate the diagnostic value of an intensive relapse surveillance strategy by regular bone marrow aspirations (BMA) in these patients. We identified 86 patients with newly diagnosed non-promyelocytic AML who had reached complete remission (CR) after intensive induction and consolidation chemotherapy between 2007 and 2019. Annual relapse rates were 40%, 17%, and 2% in years 1–3, respectively. Patients in CR were surveilled by BMA scheduled every 3 months for 2 years, followed by BMA every 6 months. This surveillance regimen detected 29 of 55 relapses (53%), 11 of which were molecular relapses (20%). The remaining 26 of 55 relapses (47%) were diagnosed by non-surveillance BMA prompted by specific suspicion of relapse. Most patients showed concurrent morphological abnormalities in peripheral blood (PB) at time of relapse. Seven percent of all morphological relapses occurred without simultaneous PB abnormalities and would have been delayed without surveillance BMA. Intensified monthly PB assessment paired with BMA every 3 months during the first 2 years may be a highly sensitive relapse surveillance strategy.
Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can affect multiple organs, among which is the circulatory system. Inflammation and mortality risk markers were previously detected in COVID-19 plasma and red blood cells (RBCs) metabolic and proteomic profiles. Additionally, biophysical properties, such as deformability, were found to be changed during the infection. Based on such data, we aim to better characterize RBC functions in COVID-19. We evaluate the flow properties of RBCs in severe COVID-19 patients admitted to the intensive care unit by using in vitro microfluidic techniques and automated methods, including artificial neural networks, for an unbiased RBC analysis. We find strong flow and RBC shape impairment in COVID-19 samples and demonstrate that such changes are reversible upon suspension of COVID-19 RBCs in healthy plasma. Vice versa, healthy RBCs immediately resemble COVID-19 RBCs when suspended in COVID-19 plasma. Proteomics and metabolomics analyses allow us to detect the effect of plasma exchanges on both plasma and RBCs and demonstrate a new role of RBCs in maintaining plasma equilibria at the expense of their flow properties. Our findings provide a framework for further investigations of clinical relevance for therapies against COVID-19 and possibly other infectious diseases.
A central motivation for the development of x-ray free-electron lasers has been the prospect of time-resolved single-molecule imaging with atomic resolution. Here, we show that x-ray photoelectron diffraction—where a photoelectron emitted after x-ray absorption illuminates the molecular structure from within—can be used to image the increase of the internuclear distance during the x-ray-induced fragmentation of an O2 molecule. By measuring the molecular-frame photoelectron emission patterns for a two-photon sequential K-shell ionization in coincidence with the fragment ions, and by sorting the data as a function of the measured kinetic energy release, we can resolve the elongation of the molecular bond by approximately 1.2 a.u. within the duration of the x-ray pulse. The experiment paves the road toward time-resolved pump-probe photoelectron diffraction imaging at high-repetition-rate x-ray free-electron lasers.
Background: Hypoxia is a key driver for infiltrative growth in experimental gliomas. It has remained elusive whether tumor hypoxia in glioblastoma patients contributes to distant or diffuse recurrences. We therefore investigated the influence of perioperative cerebral ischemia on patterns of progression in glioblastoma patients.
Methods: We retrospectively screened MRI scans of 245 patients with newly diagnosed glioblastoma undergoing resection for perioperative ischemia near the resection cavity. 46 showed relevant ischemia nearby the resection cavity. A control cohort without perioperative ischemia was generated by a 1:1 matching using an algorithm based on gender, age and adjuvant treatment. Both cohorts were analyzed for patterns of progression by a blinded neuroradiologist.
Results: The percentage of diffuse or distant recurrences at first relapse was significantly higher in the cohort with perioperative ischemia (61.1%) compared to the control cohort (19.4%). The results of the control cohort matched well with historical data. The change in patterns of progression was not associated with a difference in survival.
Conclusions: This study reveals an unrecognized association of perioperative cerebral ischemia with distant or diffuse recurrence in glioblastoma. It is the first clinical study supporting the concept that hypoxia is a key driver of infiltrative tumor growth in glioblastoma patients.
Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can affect multiple organs, among which is the circulatory system. Inflammation and mortality risk markers were previously detected in COVID-19 plasma and red blood cells (RBCs) metabolic and proteomic profiles. Additionally, biophysical properties, such as deformability, were found to be changed during the infection. Based on such data, we aim to better characterize RBC functions in COVID-19. We evaluate the flow properties of RBCs in severe COVID-19 patients admitted to the intensive care unit by using in vitro microfluidic techniques and automated methods, including artificial neural networks, for an unbiased RBC analysis. We find strong flow and RBC shape impairment in COVID-19 samples and demonstrate that such changes are reversible upon suspension of COVID-19 RBCs in healthy plasma. Vice versa, healthy RBCs immediately resemble COVID-19 RBCs when suspended in COVID-19 plasma. Proteomics and metabolomics analyses allow us to detect the effect of plasma exchanges on both plasma and RBCs and demonstrate a new role of RBCs in maintaining plasma equilibria at the expense of their flow properties. Our findings provide a framework for further investigations of clinical relevance for therapies against COVID-19 and possibly other infectious diseases.